[go: up one dir, main page]

AU2003301170A8 - Compositions for the treatment and prevention of nephropathy - Google Patents

Compositions for the treatment and prevention of nephropathy

Info

Publication number
AU2003301170A8
AU2003301170A8 AU2003301170A AU2003301170A AU2003301170A8 AU 2003301170 A8 AU2003301170 A8 AU 2003301170A8 AU 2003301170 A AU2003301170 A AU 2003301170A AU 2003301170 A AU2003301170 A AU 2003301170A AU 2003301170 A8 AU2003301170 A8 AU 2003301170A8
Authority
AU
Australia
Prior art keywords
nephropathy
prevention
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003301170A
Other versions
AU2003301170A1 (en
Inventor
Alain D Baron
Mahesh Mistry
David R Hathaway
Richard J Roman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amylin Pharmaceuticals LLC
Original Assignee
Amylin Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/740,146 external-priority patent/US7790681B2/en
Application filed by Amylin Pharmaceuticals LLC filed Critical Amylin Pharmaceuticals LLC
Publication of AU2003301170A1 publication Critical patent/AU2003301170A1/en
Publication of AU2003301170A8 publication Critical patent/AU2003301170A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
AU2003301170A 2002-12-19 2003-12-19 Compositions for the treatment and prevention of nephropathy Abandoned AU2003301170A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US74153402A 2002-12-19 2002-12-19
US60/434,888 2002-12-19
US10/740,146 US7790681B2 (en) 2002-12-17 2003-12-17 Treatment of cardiac arrhythmias with GLP-1 receptor ligands
US10/740,146 2003-12-17
PCT/US2003/040713 WO2004056317A2 (en) 2002-12-19 2003-12-19 Compositions for the treatment and prevention of nephropathy

Publications (2)

Publication Number Publication Date
AU2003301170A1 AU2003301170A1 (en) 2004-07-14
AU2003301170A8 true AU2003301170A8 (en) 2004-07-14

Family

ID=32685583

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003301170A Abandoned AU2003301170A1 (en) 2002-12-19 2003-12-19 Compositions for the treatment and prevention of nephropathy

Country Status (1)

Country Link
AU (1) AU2003301170A1 (en)

Also Published As

Publication number Publication date
AU2003301170A1 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
EP1628530A4 (en) Methods and compositions for the prevention and treatment of sepsis
TWI347188B (en) Treatment and prevention of osteoporosis
EP1644021A4 (en) Methods and compositions for the treatment of gastrointestinal disorders
SI2075000T1 (en) Combination of azelastine and ciclesonide
IL162838A0 (en) Compositions and methods for prevention and treatment peptide-of amyloid- related disorders
IL208191A0 (en) Compositions and methods for treating rage-associated disorders
AU2003291480A8 (en) Composition for the prevention and treatment of inflammation of the ear
SG106658A1 (en) Compositions and methods for the treatment of wastewater and other waste
IL165839A0 (en) Compounds useful for the treatment of cancer compositions thereof and methods therewith
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
GB0324523D0 (en) Compositions and methods of treatment
IL166062A0 (en) Compositions and methods for therapeutic treatment
AP2005003294A0 (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
EP1671648A4 (en) Prevention and treatment for gvhd
EP1560592A4 (en) Treatment of hypersensitivity conditions
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2003301170A8 (en) Compositions for the treatment and prevention of nephropathy
AU2003291461A8 (en) Compositions for diabetes treatment and prophylaxis
EP1546326A4 (en) Novel compositions and methods for the treatment of psoriasis
EP1557169A4 (en) Therapeutic and/or preventive agent for dyschezia
IL166083A0 (en) Methods for treatment and prevention of gastrointestinal conditions
IL151658A0 (en) Methods and compositions for the treatment or prevention of cardiovascular diseases
EP1491203A4 (en) Compositions for treating and/or preventing pollenosis
IL163878A0 (en) Compositions and methods for treating mdma-inducedtoxicity

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase